Patent details
EP2590970
Title:
CRYSTALLINE FORM OF RIVAROXABAN DIHYDRATE
Basic Information
- Publication number:
- EP2590970
- PCT Application Number:
- PCT/EP/2011/061283
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP117340505
- PCT Publication Number:
- WO/2012/004245
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORM OF RIVAROXABAN DIHYDRATE
- French Title of Invention:
- FORME CRISTALLINE DU RIVAROXABAN DIHYDRATÉ
- German Title of Invention:
- KRISTALLINE FORM VON RIVAROXABAN-DIHYDRAT
- SPC Number:
-
Dates
- Filing date:
- 05/07/2011
- Grant date:
- 01/10/2014
- EP Publication Date:
- 01/10/2014
- PCT Publication Date:
- 12/01/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/05/2013
- EP B1 Publication Date:
- 01/10/2014
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/07/2015
- Expiration date:
- 05/07/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/07/2011
-
-
- Name:
- Sandoz AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- ZIEGERT-KNEPPER Robert, E.
- Address:
- Austria (AT)
2
- Name:
- GRIESSER Ulrich
- Address:
- Austria (AT)
3
- Name:
- LUDESCHER Johannes
- Address:
- Austria (AT)
4
- Name:
- PICHLER Arthur
- Address:
- Austria (AT)
5
- Name:
- HADDOW Mairi
- Address:
- United Kingdom (GB)
6
- Name:
- STURM Hubert
- Address:
- Austria (AT)
Priority
- Priority Number:
- 10168536
- Priority Date:
- 06/07/2010
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
-
C07D 413/14;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |